Glenview Capital Issues Statement on CVS Health One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS).

CVS Health’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported ...

A group of HIV-positive plaintiffs filed a class action against CVS and its subsidiaries in federal court in 2018, claiming that the company’s pharmacy insurance plan violated their rights by forcing ...

Oppenheimer & Co. Inc. drastically cut its CVS Health stake in Q1, selling over 61% of its holdings. Other institutional ...